Moderate and severe anemia Haematological Disorders
Conditions
Interventions
Participants are randomised to take one of two oral supplements daily for 30 days. The iron fumarate-folic acid (IF-FA) supplement contains the elemental iron equivalent of 30 mg and 400 µg of folic a
the Medication Adherence Rating Score (MARS) tool
and the participants' perspective on adherence. For biomarker observations, hemoglobin levels are measured pre and post intervention.
Sponsors
Padjadjaran University
Teluk Bintuni General Hospital
Indonesian Ministry for Research, Technology, and Higher Education
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1. Moderate and severe anemia 2. Aged between 15–49 years 3. Consented to take part in the study
Exclusion criteria
Exclusion criteria: 1. Did not complete the informed consent 2. Incomplete data collected pre and post session 3. Unable to communicate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hemoglobin level measured using the portable analyzer HemoCue 201 at baseline and 30 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Correlation factors to the success of anemia therapy such as ethnicity, adherence to MARS and pill counting methods, and the type of supplementation, measured at baseline and 30 days | — |
Countries
Indonesia
Outcome results
None listed